Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Chiasma Inc.
DescriptionOral small molecule that utilizes Transient Permeability Enhancer technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today